News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, March 7th, suggested by Robert Orlowski
Mar 7, 2025, 14:26

Myeloma Paper of the Day, March 7th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Survival and proliferation of myeloma cells rely on splicing factor RBM39, and targeting RBM39 or MEK5 synergistically increases the cytotoxicity of bortezomib in myeloma cells via the inhibition of p65.”

“Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma”

Authors: Jia Liu et al.

Myeloma Paper of the Day, March 7th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

Bortezomib cancer Jia Liu MD Anderson Cancer Center multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski
Special Coverage
Blog
May 21, 2025, 07:32
Ruben Mesa: Grateful to Take On a New Role as Clinical Leader for Advocate Health’s National Cancer Program
Blog
May 21, 2025, 07:25
Benedikt Westphalen Shares Final ESMO Recommendations for Molecular Tumour Boards
Blog
May 21, 2025, 07:16
Albert Koong: A Gathering of MD Anderson Physicists Could Disturb the Force
Blog
May 21, 2025, 07:09
Daniel Sumarriva: I’m Starting a New Position as Executive Medical Director at SAGA Diagnostics
Blog
May 21, 2025, 07:01
Together, She Changed Everything: Martine Piccart’s Fight Against Breast Cancer - CancerWorld
Blog
May 21, 2025, 06:44
Vivek Subbiah: Clinical Trials are Essential for Medical Advancement
Blog
May 21, 2025, 06:37
Hesham ElGhazaly: First Cancer Planners Forum by UICC
Blog
May 21, 2025, 06:28
Irina Ghazaryan Explores Uzbekistan's Healthcare Market at Plug and Play Expo
Blog
May 21, 2025, 06:19
George Kapetanakis: Honored to Participate at Cancer Planners Forum!
Blog
May 21, 2025, 06:06
Mandy Davis Aitken: We are Getting Ready for ASCO25, Are you?
Blog
May 21, 2025, 06:00
Charles Mullighan Has Been Elected as a Fellow of The Royal Society of London - St. Jude Children's Research Hospital
Blog
May 21, 2025, 05:49
Natalia Baran: GD3 Synthase Drives Resistance to p53-Induced Apoptosis in Breast Cancer by Modulating Mitochondrial Function